EEG is the Wave of the Future: Machine Learning Technology Highlighted in Biological Psychiatry Publication
/
Date28 Sep 2016
MISSION VIEJO, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) — MYnd Analytics, Inc. (OTCQB:CNSOD) announces the publication of “Using Electroencephalography for Treatment Guidance in Major Depressive... Read More →
Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced Fibrosis
/
Date27 Sep 2016
Larger Phase 2b clinical trial in NASH cirrhosis (NASH-CX) now completely enrolled Closed private placement financing for $1.5 million Conference call to be held today... Read More →
Companion Diagnostics Market worth 5.58 Billion USD by 2019; Transparency Market Research
/
Date27 Sep 2016
Albany – New York, Sept. 27, 2016 (GLOBE NEWSWIRE) — The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to... Read More →
Clinical Trial Management System (CTMS) Market worth 1,848.5 Million USD by 2019; Web-based CTMS Solutions in Demand in North America
/
Date27 Sep 2016
Albany – New York, Sept. 27, 2016 (GLOBE NEWSWIRE) — A new Transparency Market Research report states that the global clinical trial management system (CTMS)... Read More →
Healthcare Cloud Computing Market worth 6.8 Billion USD by 2018; Increasing Awareness about Benefits of Cloud Architecture Crucial for Adoption of Cloud Computing; TMR
/
Date27 Sep 2016
Albany – New York, Sept. 27, 2016 (GLOBE NEWSWIRE) — The moderately fragmented cloud computing market in the healthcare industry is dominated by companies such... Read More →
Contraceptives Market worth 19.6 Billion USD by 2020; Transparency Market Research
/
Date27 Sep 2016
Albany – New York, Sept. 27, 2016 (GLOBE NEWSWIRE) — In a new report, titled ‘Contraceptives Market – Global Industry Analysis, Size, Share, Growth, Trends... Read More →
Summit Receives Rare Pediatric Disease Designation From US FDA for Ezutromid in Treatment of Duchenne Muscular Dystrophy
/
Date27 Sep 2016
OXFORD, United Kingdom, Sept. 27, 2016 (GLOBE NEWSWIRE) — Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular... Read More →
MDxHealth Announces Independence Blue Cross Rendered Positive Medical Coverage Policy for ConfirmMDx
/
Date27 Sep 2016
IRVINE, Calif., and HERSTAL, Belgium, Sept. 27, 2016 (GLOBE NEWSWIRE) — MDxHealth SA (Euronext: MDXH.BR) announced that Independence Blue Cross (Independence) has issued a positive... Read More →
Advaxis’ Lm Technology Immunotherapies to be Showcased in Three Poster Presentations at SITC Annual Meeting
/
Date26 Sep 2016
PRINCETON, N.J., Sept. 26, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced three poster presentations have... Read More →
MDwise Partners with Valence Health To Support Health Plans
/
Date26 Sep 2016
CHICAGO, Sept. 26, 2016 (GLOBE NEWSWIRE) — Valence Health, a leading provider of clinical integration, population health, and value-based care solutions and services, today announced... Read More →